EGF-receptor and Papillary Thyroid Carcinoma
Author Information
Author(s): L.A. Akslen, A.O. Myking, H. Salvesen, J.E. Varhaug
Primary Institution: University of Bergen
Hypothesis
The study aims to investigate the prognostic importance of EGF-receptor expression in papillary thyroid carcinomas.
Conclusion
Strong cytoplasmic EGF-receptor staining is associated with extra-thyroidal growth and decreased recurrence-free survival in papillary thyroid carcinoma patients.
Supporting Evidence
- 96% of the cases showed EGF-receptor immunostaining.
- Strong cytoplasmic staining was significantly associated with extra-thyroidal growth.
- Cytoplasmic EGF-receptor staining was an independent predictor of tumor recurrences.
- 22% of patients experienced tumor recurrences during the follow-up period.
Takeaway
This study found that a protein called EGF-receptor is present in most thyroid cancer cases, and when it's found strongly in the cells, it can mean the cancer might come back.
Methodology
The study involved a retrospective analysis of EGF-receptor expression in 125 surgically treated papillary thyroid carcinoma cases using immunohistochemistry.
Limitations
The study excluded microcarcinomas and relied on retrospective data, which may limit the generalizability of the findings.
Participant Demographics
{"males":36,"females":89,"age_0_49_years":71,"age_50_plus_years":54}
Statistical Information
P-Value
{"cytoplasmic_staining":0.006,"lymph_node_metastases":0.0009}
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website